Article
NEW YORK - Metastatic melanoma of the brain has a terrible prognosis, with a median survival of three to four months.
Psychosocial Impact of Alopecia Areata on Pediatric and Adolescent Patients
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Unmasking Botulinum Toxin Myths
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors
Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy